GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of “Moderate Buy” by Analysts

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has received an average recommendation of “Moderate Buy” from the eleven research firms that are currently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $95.00.

GEHC has been the subject of a number of research reports. Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and raised their price target for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Bank of America reduced their price objective on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday. Argus raised their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Finally, Citigroup upped their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd.

GE HealthCare Technologies Trading Up 2.1 %

GEHC opened at $79.47 on Friday. The company has a market cap of $36.27 billion, a P/E ratio of 23.24, a PEG ratio of 2.80 and a beta of 1.26. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The company’s 50 day moving average is $88.25 and its 200-day moving average is $78.89. GE HealthCare Technologies has a 1-year low of $62.35 and a 1-year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.90. The firm had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.80 billion. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The company’s revenue was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.85 earnings per share. Equities research analysts predict that GE HealthCare Technologies will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Insider Activity at GE HealthCare Technologies

In related news, insider Frank R. Jimenez purchased 1,315 shares of GE HealthCare Technologies stock in a transaction on Wednesday, May 1st. The stock was acquired at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the acquisition, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. 0.27% of the stock is owned by corporate insiders.

Institutional Trading of GE HealthCare Technologies

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BNP Paribas acquired a new stake in GE HealthCare Technologies in the first quarter valued at approximately $30,000. Rise Advisors LLC increased its stake in GE HealthCare Technologies by 241.4% during the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after purchasing an additional 239 shares in the last quarter. Riverview Trust Co acquired a new position in GE HealthCare Technologies during the first quarter worth $31,000. Annapolis Financial Services LLC lifted its stake in shares of GE HealthCare Technologies by 171.9% in the first quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock valued at $32,000 after buying an additional 220 shares in the last quarter. Finally, First Command Advisory Services Inc. grew its holdings in shares of GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after buying an additional 369 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.